The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

47 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
44
Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo.EBI
Anhui Medical University
19
Novel tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one: Design, synthesis, model and use as hMAO-B inhibitors.EBI
Anhui Medical University
11
Design and synthesis of celastrol derivatives as anticancer agents.EBI
Anhui Medical University
9
Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.EBI
Anhui Medical University
36
Design and synthesis of novel 2-pyrazoline-1-ethanone derivatives as selective MAO inhibitors.EBI
Anhui Medical University
16
New coumarin derivatives: design, synthesis and use as inhibitors of hMAO.EBI
Anhui Medical University
19
New 2H-chromene-3-carboxamide derivatives: design, synthesis and use as inhibitors of hMAO.EBI
Anhui Medical University
9
Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.EBI
Anhui Medical University
7
Design and synthesis of novel 5-phenyl-N-piperidine ethanone containing 4,5-dihydropyrazole derivatives as potential antitumor agents.EBI
Anhui Medical University
23
Discovery of the 2,3-Dihydrobenzopyrane-4-one as a Potent FTO Inhibitor against Obesity-Related Metabolic Diseases.EBI
Anhui Medical University
37
Discovery of Potent and Balanced Dual RIPK2 and 3 Inhibitors as a New Strategy for the Treatment of Inflammatory Bowel Diseases.EBI
Anhui Medical University
79
Identification of novel indolinone derivatives as CTSC inhibitors to treat inflammatory bowel disease by modulating inflammatory factors.EBI
Anhui Medical University
31
Discovery of N-Phenyl-5-propyl-1H-pyrazole-3-carboxamide, with Selective Inhibition and Degradation of HDAC6 for the Treatment of Acute Liver Injury.EBI
Anhui Medical University
34
Natural phenol carbamates: Selective BuChE/FAAH dual inhibitors show neuroprotection in an Alzheimer's disease mouse model.EBI
Anhui Medical University
1
Design and synthesis of 7-azaindole derivatives as potent CDK8 inhibitors for the treatment of acute myeloid leukemia.EBI
Anhui Medical University
18
Sulfur-fluoride exchange (SuFEx)-enabled lead discovery of AChE inhibitors by fragment linking strategies.EBI
Anhui Medical University
1
Discovery of highly potent and selective VEGFR2 kinase inhibitors for the treatment of rheumatoid arthritis.EBI
Anhui Medical University
1
Design, synthesis and biological evaluation of indazole derivatives as VEGFR-2 kinase inhibitors with anti-angiogenic properties.EBI
Anhui Medical University
1
Discovery of novel CXCR4 inhibitors for the treatment of inflammation by virtual screening and biological evaluation.EBI
Anhui Medical University
38
Discovery of novel deoxyvasicinone derivatives with benzenesulfonamide substituents as multifunctional agents against Alzheimer's disease.EBI
Anhui Medical University
6
Drug discovery and optimization based on the co-crystal structure of natural product with target.EBI
Anhui Medical University
1
Discovery of novel diaryl substituted isoquinolin-1(2H)-one derivatives as hypoxia-inducible factor-1 signaling inhibitors for the treatment of rheumatoid arthritis.EBI
Anhui Medical University
23
Discovery of a novel oral type Ⅰ CDK8 inhibitor against acute myeloid leukemia.EBI
Anhui Medical University
4
Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo.EBI
Anhui Medical University
34
Discovery and Anti-Inflammatory Activity Evaluation of a Novel CDK8 Inhibitor through Upregulation of IL-10 for the Treatment of Inflammatory Bowel Disease EBI
Anhui Medical University
47
Non-peptidyl non-covalent cathepsin C inhibitoEEr bearing a unique thiophene-substituted pyridine: Design, structure-activity relationship and anti-inflammatory activity in vivo.EBI
Anhui Medical University
1
Synthesis and biological evaluation of novel hybrids of phenylsulfonyl furoxan and phenstatin derivatives as potent anti-tumor agents.EBI
Anhui Medical University
25
Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease.EBI
Anhui Medical University
2
Novel quinoline-based derivatives: A new class of PDE4B inhibitors for adjuvant-induced arthritis.EBI
Anhui Medical University
28
Discovery of the Novel 1EBI
Anhui Medical University
32
Design and Synthesis of a 2-Amino-pyridine Derivative as a Potent CDK8 Inhibitor for Anti-colorectal Cancer Therapy.EBI
Anhui Medical University
14
Discovery of Novel Pterostilbene-Based Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors with Inflammatory Activity for Colitis.EBI
Anhui Medical University
20
Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.EBI
Anhui Medical University
74
Discovery and EBI
Anhui Medical University
15
Discovery and development of novel pyrimidine and pyrazolo/thieno-fused pyrimidine derivatives as potent and orally active inducible nitric oxide synthase dimerization inhibitor with efficacy for arthritis.EBI
Anhui Medical University
27
Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents.EBI
Anhui Medical University
50
The structure-based optimization of δ-sultone-fused pyrazoles as selective BuChE inhibitors.EBI
Anhui Medical University
53
Discovery and SARs of 5-Chloro-EBI
Anhui Medical University
31
Discovery of δ-sultone-fused pyrazoles for treating Alzheimer's disease: Design, synthesis, biological evaluation and SAR studies.EBI
Anhui Medical University
17
Discovery of Novel Aryl Carboxamide Derivatives as Hypoxia-Inducible Factor 1α Signaling Inhibitors with Potent Activities of Anticancer Metastasis.EBI
Anhui Medical University
9
Novel Pyrazolo[4,3- d]pyrimidine as Potent and Orally Active Inducible Nitric Oxide Synthase (iNOS) Dimerization Inhibitor with Efficacy in Rheumatoid Arthritis Mouse Model.EBI
Anhui Medical University
23
Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.EBI
Anhui Medical University
1
Novel curcumin analogue hybrids: Synthesis and anticancer activity.EBI
Anhui Medical University
7
Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.EBI
Anhui Medical University
9
Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors.EBI
Anhui Medical University
2
Novel amidrazone derivatives: Design, synthesis and activity evaluation.EBI
Anhui Medical University
158
Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitorsBDB
Incyte